Is Anthera Pharmaceuticals, Inc. (ANTH) a Buy, Sell, or Hold?
OTC : ANTH
Anthera Pharmaceuticals, Inc. — News
$0.0001 USD
$0 (0.0%)
- Volume
- 108
- Average Volume
- 2.26K
- Market Capitalization
- $2.62K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.68
| Source | Headline |
|---|---|
|
AMD and Cerbras Create A New Blueprint For Hardware
Artificial intelligence (AI) infrastructure is hitting a physical wall. As large language models grow exponentially in size, the legacy approach of throwing large, monolithic graphics processing units at the problem breaks down during the inference phase. marketbeat.com - 2026-07-24 12:10:26 |
|
SpaceX Lost $1 Trillion In A Week. So Why Did Bond Investors Rush To Lend It $20 Billion?
Space Exploration Technologies Corp. (NASDAQ:SPCX) has lost more than $1 trillion in market value since reaching a roughly $3 trillion valuation last week. At first glance, that sounds like a company in trouble. benzinga.com - 2026-06-23 08:43:40 |
